Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Antithrombin A.10. Why do patients with ESLD have abnormalities of hemostasis? B.4. What hematologic changes occur during pregnancy? C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.II-1. What anticoagulant would you give before cardiopulmonary bypass (CPB)? How much would you give? What is its mechanism?
antithrombin III C.II-1. What anticoagulant would you give before cardiopulmonary bypass (CPB)? How much would you give? What is its mechanism? C.III-1. How would you reverse heparin? How much protamine would you use? What are the other drugs used to neutralize heparin?
Anti-thymocyte globulin A.9. How are immunosuppressive drugs managed in kidney transplant recipients? D.1. What are the major complications after lung transplantation? D.6. What immunosuppressive agents will be given after liver transplantation? What are the major side effects?
APAP
APD
Aprepitant B.11. What is an enhanced recovery after surgery (ERAS) protocol, and how would you apply it in the outpatient setting? B.5. Would you premedicate this patient? B.6. Describe the mechanism of action of each premedication in the ENERGY protocol. C.8. What components of ERAS are applied in the intraoperative phase of the care of patients undergoing CRS? D.2. How would you pharmacologically prevent PONV in the susceptible ambulatory patient?
Aprotinin B.8. Explain the technical and physiologic principles behind rotational thromboelastometry. C.22. What is thromboelastometry? How can it guide transfusion? C.I-17. What antifibrinolytic will you use to reduce blood transfusions?
Artemisia vulgaris
ASA
Aspirin
Atenolol A.14. What is the mechanism of action of the major antihypertensive drugs? A.3. What implications does the use of atenolol have on the patient's coexisting medical condition? A.6. Which perioperative medical therapies would you employ to reduce the incidence of myocardial ischemia? Brachial Plexus Block C.9. Would this patient benefit from the use of -blockers? Electroconvulsive Therapy Ischemic Heart Disease and Noncardiac Surgery
Atorvastatin B.6. The surgery was postponed for 6 weeks. The patient presents for surgery again, currently on a regimen of metoprolol, aspirin, atorvastatin, captopril, hydrochlorothiazide, and potassium chloride. Their BP is 160/60 mm Hg and potassium 4.0 mEq/L. Would you premedicate this patient? Diabetes Mellitus Hypertension
Atracurium B.12. What are the limitations of acetylcholinesterase antagonists? B.14. Is reversal of NMB always necessary? B.2. What factors can alter sensitivity to nondepolarizing NMBAs? B.7. How would you adjust doses of anesthetics in the morbidly obese? B.8. How accurate are qualitative estimates of the TOF ratio, and what purpose do peripheral nerve stimulator (PNS) monitors serve? Burns C.1. What drugs should be avoided during the operation? C.10. Which neuromuscular blocking agents would you use? Why? C.13. How are neuromuscular blocking agents, such as succinylcholine, atracurium, cisatracurium, vecuronium, pancuronium, rocuronium, and curare, metabolized and eliminated? Which have significant histamine release? C.3. How would you induce anesthesia in this patient? C.5. How are nondepolarizing neuromuscular blockers affected by renal failure? C.7. How will you perform a rapid sequence induction of anesthesia and tracheal intubation without using succinylcholine? E.9. What are the significant implications of drug interactions?
Atropine
Avandia
Azathioprine A.7. What treatments are available for a patient with MG? A.9. How are immunosuppressive drugs managed in kidney transplant recipients? D.1. What are the major complications after lung transplantation? D.2. What are immunosuppressive agents, and how do they affect anesthetic care? D.6. What immunosuppressive agents will be given after liver transplantation? What are the major side effects? E.9. What are the significant implications of drug interactions?
Azithromycin